EP
CRL icon

Edgestream Partners’s Charles River Laboratories CRL Stock Holding History

Edgestream Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
+9,036
New +$1.68M 0.05% 551
2025
Q4 		– Sell
-26,667
Closed -$4.17M – 973
2025
Q3 		$4.17M Buy
26,667
+14,820
+125% +$2.35M 0.12% 312
2025
Q2 		$1.8M Buy
+11,847
New +$1.58M 0.05% 548
2025
Q1 		– Sell
-12,880
Closed -$2.38M – 880
2024
Q4 		$2.38M Buy
+12,880
New +$2.48M 0.1% 360
2024
Q3 		– Sell
-16,725
Closed -$3.46M – 877
2024
Q2 		$3.46M Buy
+16,725
New +$3.79M 0.17% 207
2022
Q1 		– Sell
-9,672
Closed -$3.64M – 549
2021
Q4 		$3.64M Buy
9,672
+5,524
+133% +$2.15M 0.23% 140
2021
Q3 		$1.71M Buy
+4,148
New +$1.72M 0.11% 258

Other funds holding CRL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $74.9B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return